TELA Bio (TELA) Return on Capital Employed Growth (1y) (2020 - 2026)
TELA Bio (TELA) Return on Capital Employed Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.30 Bn | 175.00 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 128.77 Bn | 125.89 Bn | 3.81 Bn | -1,390.00 |
| 3 | Medtronic | 107.99 Bn | 98.77 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 67.85 Bn | 66.39 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 48.12 Bn | 44.45 Bn | 1.29 Bn | -110.00 |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 658.00 |
| 7 | GE HealthCare Technologies | 27.98 Bn | 25.70 Bn | 1.98 Bn | -3,185.00 |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.78 Bn | 20.65 Bn | 2.07 Bn | 125.00 |
| 10 | TELA Bio | 38.25 Mn | -1.29 Mn | 12.52 Mn | 235.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 235.00 |
| Dec 31, 2025 | -11.00 |
| Sep 30, 2025 | 2,117.00 |
| Jun 30, 2025 | 625.00 |
| Mar 31, 2025 | 217.00 |
| Dec 31, 2024 | 412.00 |
| Sep 30, 2024 | -4,109.00 |
| Jun 30, 2024 | -1,234.00 |
| Mar 31, 2024 | 1,963.00 |
| Dec 31, 2023 | -344.00 |
| Sep 30, 2023 | 1,949.00 |
| Jun 30, 2023 | 2,058.00 |
| Mar 31, 2023 | -1,399.00 |
| Dec 31, 2022 | -1,018.00 |
| Sep 30, 2022 | -2,800.00 |
| Jun 30, 2022 | -4,339.00 |
| Mar 31, 2022 | -3,470.00 |
| Dec 31, 2021 | -2,292.00 |
| Sep 30, 2021 | -1,891.00 |
| Jun 30, 2021 | -1,237.00 |